Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jun:220:265-266.
doi: 10.1016/j.schres.2020.04.030. Epub 2020 Apr 27.

Long-acting injectable antipsychotics treatment during COVID-19 pandemic - A new challenge

Affiliations

Long-acting injectable antipsychotics treatment during COVID-19 pandemic - A new challenge

Petru Ifteni et al. Schizophr Res. 2020 Jun.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest None of the authors have conflicts to report.

Comment in

References

    1. Dobber J. Medication adherence in patients with schizophrenia: a qualitative study of the patient process in motivational interviewing. BMC Psychiatry. 2018;18(1):135. doi: 10.1186/s12888-018-1724-9. - DOI - PMC - PubMed
    1. Haddad P.M., Brain C., Scott J. Nonadherence with antipsychotic medication in schizophrenia: challenges and management strategies. Patient Relat. Outcome Meas. 2014;5:43–62. doi: 10.2147/PROM.S42735. - DOI - PMC - PubMed
    1. Ifteni P.I., Teodorescu A. Prevention of catatonia with olanzapine long-acting injectable. Am. J. Ther. 2017;24(5):e599–e601. doi: 10.1097/MJT.0000000000000479. - DOI - PubMed
    1. Kane J.M., Kishimoto T., Correll C.U. Non-adherence to medication in patients with psychotic disorders: epidemiology, contributing factors and management strategies. World Psychiatry. 2013;12(3):216–226. doi: 10.1002/wps.20060. - DOI - PMC - PubMed
    1. Kane J.M., Kishimoto T., Correll C.U. Assessing the comparative effectiveness of long-acting injectable vs. oral antipsychotic medications in the prevention of relapse provides a case study in comparative effectiveness research in psychiatry. J. Clin. Epidemiol. 2013;66(8 Suppl):S37–S41. doi: 10.1016/j.jclinepi.2013.01.012. - DOI - PMC - PubMed

MeSH terms

Substances